Compass Pathways Plc ADR (CMPS)

$5.82 +0.14 (2.46%)
Market Cap 558.82M
Revenue (ttm) 0.00
Net Income (ttm) -155.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.83
Volume 1,604,200
Avg Vol 1,805,178
Day's Range N/A - N/A
Shares Out 96.02M
Stochastic %K 92%
Beta 1.93
Analysts Strong Sell
Price Target $16.80

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
BobJohnBuoy666
BobJohnBuoy666 Dec. 7 at 3:07 PM
$CMPS highest institutional buy volume going all the way back to 2021 while price is near all time lows.
0 · Reply
Tifosi007
Tifosi007 Dec. 6 at 4:23 PM
$ATAI $CMPS @ClownThePoet 1yr chart shows 38% vs 170% Smart investing vs Penny flipping attitude You decide which one you belong to👍
1 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 8:09 PM
$CMPS 6 EoD plzzz
0 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 7:20 PM
$CMPS green $ATAI red
2 · Reply
BobJohnBuoy666
BobJohnBuoy666 Dec. 5 at 6:47 PM
$CMPS I like it
0 · Reply
Suprememsg
Suprememsg Dec. 5 at 4:23 PM
$CMPS 🧐💡
0 · Reply
aaronmag13
aaronmag13 Dec. 5 at 3:41 PM
$CMPS made all my money back on Google from my previous loss here and almost came back in but wanted 4.75 and didn’t get it haha.
0 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 3:16 PM
$CMPS LET’S GO BOYS
0 · Reply
FBP
FBP Dec. 5 at 2:49 PM
$CMPS testing pennant
0 · Reply
BankOnTheFuture
BankOnTheFuture Dec. 5 at 1:21 AM
$CMPS "We are preparing for commercial launch end of 2026" -CEO statement at 4:30 mark of interview
2 · Reply
Latest News on CMPS
Compass Pathways to Participate in Two Investor Conferences in December

Nov 20, 2025, 6:30 AM EST - 17 days ago

Compass Pathways to Participate in Two Investor Conferences in December

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Nov 5, 2025, 6:30 AM EST - 4 weeks ago

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:16 AM EST - 4 weeks ago

COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript

Compass Pathways to expedite launch timing of its experimental depression therapy

Nov 4, 2025, 6:45 AM EST - 4 weeks ago

Compass Pathways to expedite launch timing of its experimental depression therapy

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Nov 4, 2025, 6:30 AM EST - 4 weeks ago

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

Oct 30, 2025, 8:30 AM EDT - 5 weeks ago

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Oct 29, 2025, 6:30 AM EDT - 5 weeks ago

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Oct 28, 2025, 6:30 AM EDT - 5 weeks ago

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 2:03 PM EDT - 3 months ago

COMPASS Pathways Plc (CMPS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 4:56 AM EDT - 3 months ago

COMPASS Pathways Plc (CMPS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Sep 2, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Compass Pathways to Participate in Four Investor Conferences in September

Aug 27, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Aug 5, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Compass (CMPS) Q2 Loss Improves 27%

Aug 1, 2025, 1:16 AM EDT - 4 months ago

Compass (CMPS) Q2 Loss Improves 27%

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 10:32 AM EDT - 4 months ago

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 31, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 29, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Appoints Justin Gover to Board of Directors

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 22, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?

Jul 20, 2025, 4:48 AM EDT - 5 months ago

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?

VKTX

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jul 10, 2025, 4:00 PM EDT - 5 months ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 24, 2025, 2:47 PM EDT - 5 months ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jun 23, 2025, 8:25 AM EDT - 5 months ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 8:12 AM EDT - 5 months ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 5 months ago

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Jun 23, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:14 AM EDT - 7 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 29, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 28, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Why Compass Pathways Stock Was a Double-Digit Winner This Week

Apr 25, 2025, 6:13 PM EDT - 8 months ago

Why Compass Pathways Stock Was a Double-Digit Winner This Week

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Apr 22, 2025, 6:00 AM EDT - 8 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 9 months ago

This Is a Test From GlobeNewswire

ALVO

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 26, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in Stifel Virtual CNS Forum

Mar 11, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 28, 2025, 5:08 PM EST - 10 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 4:02 PM EST - 10 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:41 AM EST - 10 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 27, 2025, 6:30 AM EST - 10 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 4:00 PM EST - 10 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 18, 2025, 6:30 AM EST - 10 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 6:30 AM EST - 10 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 21, 2025, 6:30 AM EST - 11 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025, 7:01 AM EST - 11 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Dec 18, 2024, 6:30 AM EST - 1 year ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Compass Pathways to Participate in December Investor Conferences

Nov 25, 2024, 4:00 PM EST - 1 year ago

Compass Pathways to Participate in December Investor Conferences

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 14, 2024, 7:44 AM EST - 1 year ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Top 3 Health Care Stocks You'll Regret Missing In November

Nov 5, 2024, 6:58 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 1, 2024, 5:10 PM EDT - 1 year ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

BobJohnBuoy666
BobJohnBuoy666 Dec. 7 at 3:07 PM
$CMPS highest institutional buy volume going all the way back to 2021 while price is near all time lows.
0 · Reply
Tifosi007
Tifosi007 Dec. 6 at 4:23 PM
$ATAI $CMPS @ClownThePoet 1yr chart shows 38% vs 170% Smart investing vs Penny flipping attitude You decide which one you belong to👍
1 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 8:09 PM
$CMPS 6 EoD plzzz
0 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 7:20 PM
$CMPS green $ATAI red
2 · Reply
BobJohnBuoy666
BobJohnBuoy666 Dec. 5 at 6:47 PM
$CMPS I like it
0 · Reply
Suprememsg
Suprememsg Dec. 5 at 4:23 PM
$CMPS 🧐💡
0 · Reply
aaronmag13
aaronmag13 Dec. 5 at 3:41 PM
$CMPS made all my money back on Google from my previous loss here and almost came back in but wanted 4.75 and didn’t get it haha.
0 · Reply
ClownThePoet
ClownThePoet Dec. 5 at 3:16 PM
$CMPS LET’S GO BOYS
0 · Reply
FBP
FBP Dec. 5 at 2:49 PM
$CMPS testing pennant
0 · Reply
BankOnTheFuture
BankOnTheFuture Dec. 5 at 1:21 AM
$CMPS "We are preparing for commercial launch end of 2026" -CEO statement at 4:30 mark of interview
2 · Reply
twiggs462
twiggs462 Dec. 5 at 12:31 AM
$CMPS $MNMD $ATAI Compass Pathways Eyes FDA Approval for Psilocybin Depression Drug https://www.youtube.com/watch?v=qoJVsHs04vo Whole sector about to take off.
0 · Reply
InvestorWisdom
InvestorWisdom Dec. 4 at 10:36 PM
$CMPS here’s the CEO on Bloomberg today… Compass Pathways Eyes FDA Approval for Psilocybin Depression Drug https://www.bloomberg.com/news/videos/2025-12-04/bloomberg-businessweek-daily-12-4-2025-video
0 · Reply
BobbyCucumber
BobbyCucumber Dec. 4 at 9:51 PM
$CMPS
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Dec. 4 at 8:58 PM
$CMPS stupid large buy orders today
0 · Reply
ClownThePoet
ClownThePoet Dec. 4 at 8:04 PM
$CMPS $SPY $QQQ
0 · Reply
InvestorWisdom
InvestorWisdom Dec. 4 at 7:49 PM
$CMPS the CEO was just on Bloomberg and said that they could be selling this drug in 2026, but I can’t find the video online yet… with the head of the FDA being pro psychedelics, it could get fast tracked now that it’s proving results with little to no negative side effects here’s what he said back in July… https://www.bloomberg.com/news/videos/2025-07-29/rfk-jr-hints-fda-approval-of-psychedelic-therapy-hope-video
0 · Reply
InvestorWisdom
InvestorWisdom Dec. 4 at 7:34 PM
$CMPS This one could run much higher. 
1 · Reply
ClownThePoet
ClownThePoet Dec. 4 at 7:32 PM
$CMPS SEND US TO 6 EOD
0 · Reply
DriuxP
DriuxP Dec. 4 at 4:32 PM
$ATAI wholeheartedly agree with the "winner takes most" sentiment. And 90% of people will get in after that realization. It will be a few players that take this to infinity and beyond, but the initial onset will be explosive and be talked about like tech is talked about now. Personal health is the next revolution, the writing is on the wall. Sit pretty, we are positioned well for success here. IYKYK $PSIL $CMPS
2 · Reply
BobJohnBuoy666
BobJohnBuoy666 Dec. 4 at 3:53 PM
$CMPS if can break out of wedge and keep it, 5.90 is next level of resistance
0 · Reply
HedgeAlerts
HedgeAlerts Dec. 4 at 7:34 AM
Hedge Alert Live - Protect Your Portfolio Contract: $CMPS $5.00 Put · DEC 19, 2025 Exp Entry Price: $0.30 - $0.50 Exit Price Target: $0.49 Profit Margin: +62% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
AndyFromTheFuture
AndyFromTheFuture Dec. 3 at 10:51 PM
What GLP-1 agonists did for obesity, psychedelic medicine may soon do for mental health. $MNMD $ATAI $CMPS https://andyfromthefuture.substack.com/p/are-psychedelics-the-new-glp-1s
2 · Reply